Cystic fibrosis - general review on sinonasal complications and case report

Claudiu Manea; Alina Diaconescu

doi:10.1515/rjr-2017-0004

.blurhash-client-img { display: none !important; }

Cystic fibrosis - general review on sinonasal complications and case report

Romanian Journal of Rhinology

Volume 7 (2017): Issue 25 (March 2017)

By: Claudiu Manea and Alina Diaconescu

Open Access

|Mar 2017

Abstract

An irreversible disease, cystic fibrosis (CF), is responsible for affecting multiple organ systems containing epithelia. It is well known that the sinonasal disease caused by CF has consequences for the incidence of the lower airway exacerbations, as well as affecting the quality of life of those patients. This review provides an update by evaluating the available literature regarding pathogenesis, management and treatment of cystic fibrosis patients. To gain a better view of the disease and obtain a higher life expectancy, further studies are needed.

References

1. Rowe S.M., Miller S., Sorscher E.J. - Cystic fibrosis. N Engl J Med., 2005;352(19):1992-2001.
Search in Google Scholar Back to article
2. Cystic Fibrosis Foundation Patient Registry 2011 Annual Data Report. Bethesda, MD: Cystic Fibrosis Foundation, 2012.
Search in Google Scholar Back to article
3. Oomen K.P., April M.M. - Sinonasal manifestations in Cystic fibrosis. Int J Otolaryngol., 2012;2012:789572. doi: 10.1155/2012/789572. Epub 2012 Aug 5.10.1155/2012/789572
Search in Google Scholar Back to article
4. Brihaye P., Jorissen M., Clement P.A. - Chronic rinosinusistis in cystic fibrosis (mucoviscidosis). Acta Otorhinolaryngol Belg., 1997;51(4):323-337.
Search in Google Scholar Back to article
5. Steinke J.W., Payne S.C., Chen P.G., Negri J., Stelow E.B., Borish L. - Etiology of nasal polyps in cystic fiborisis: not a unimodal disease. Ann Otol Rhinol Laryngol., 2012;121(9):579-586.
Search in Google Scholar Back to article
6. Tabor A., Alfirevic Z. - Update on procedure-related risks for prenatal diagnosis techniques. Fetal Diagn Ther., 2010;27(1):1–7. doi: 10.1159/000271995. Epub 2009 Dec 24.10.1159/000271995
Search in Google Scholar Back to article
7. Gentile V.G., Isaacson G. - Patterns of sinusitis in cystic fibrosis. Laryngoscope, 1996;106(8):1005-1009.10.1097/00005537-199608000-00018
Search in Google Scholar Back to article
8. Shapiro E.D., Milmoe G.J., Wald E.R., Rodnan J.B., Bowen A.D. - Bacteriology of the maxillary sinuses in patients with cystic fibrosis. J Infect Dis., 1982;146(5):589–593.
Search in Google Scholar Back to article
9. Halvorson D.J., Dupree J.R., Porubsky E.S. - Management of chronic sinusitis in the adult cystic fibrosis patient. Ann Otol Rhinol Laryngol., 1998;107(11 Pt 1):946–952.10.1177/000348949810701108
Search in Google Scholar Back to article
10. Mak G.K., Henig N.R. - Sinus disease in cystic fibrosis. Clin Rev Allergy Immunol., 2001;21(1):51–63.
Search in Google Scholar Back to article
11. Moss R.B., King V.V. - Management of sinusitis in cystic fibrosis by endoscopic surgery and serial antimicrobial lavage. Reduction in recurrence requiring surgery. Arch Otolaryngol Head Neck Surg., 1995;121(5):566–572.
Search in Google Scholar Back to article
12. Godoy J.M., Godoy A.N., Ribalta G., Largo I. - Bacterial pattern in chronic sinusitis and cystic fibrosis. Otolaryngol Head Neck Surg., 2011;145(4):673–676. doi: 10.1177/0194599811407279. Epub 2011 Apr 26.10.1177/0194599811407279
Search in Google Scholar Back to article
13. Robertson J.M., Friedman E.M., Rubin B.K. - Nasal and sinus disease in cystic fibrosis. Paediatr Respir Rev., 2008;9(3):213–219. doi: 10.1019/j.prrv.2008.04.003. Epub 2008 Jul 31.
Search in Google Scholar Back to article
14. Van Zele T., Claeys S., Gevaert P., Van Maele G., Holtappels G., Van Cauwenberger P., Bachert C. - Differentiation of chronic sinus diseases by measurement of inflammatory mediators. Allergy, 2006;61(11):1280–1289.10.1111/j.1398-9995.2006.01225.x
Search in Google Scholar Back to article
15. Welsh M.J., Smith A.E. - Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis. Cell, 1993;73(7):1251–1254.10.1016/0092-8674(93)90353-R
Search in Google Scholar Back to article
16. Accurso F.J., Rowe S.M., Clancy J.P., et al. - Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation. N Engl J Med., 2010;363(21):1991–2003. doi: 10.1056/NEJmoa0909825.10.1056/NEJMoa0909825
Search in Google Scholar Back to article
17. Gan K.H., Veeze H.J., van den Ouweland A., et al. - A cystic fibrosis mutation associated with mild lung disease. N Engl J Med., 1995;333:95–99.
Search in Google Scholar Back to article
18. Haardt M., Benharouga M., Lechardeur D., Kartner N., Lukacs G.L. - C-terminal truncations destabilize the cystic fibrosis transmembrane conductance regulator without impairing its biogenesis. A novel class of mutation. J Biol Chem., 1999;274(31):21873–21877.
Search in Google Scholar Back to article
19. Woodworth B.A., Ahn C., Flume P.A., Schlosser R.J. - The delta F508 mutation in cystic fibrosis and impact on sinus development. Am J Rhinol., 2007;21(1):122–127.
Search in Google Scholar Back to article
20. Nishioka G.J., Cook P.R., McKinsey J.P., Rodriguez F.J. - Paranasal sinus computed tomography scan findings in patients with cystic fibrosis. Otolayngol Head Neck Surg., 1996:114(3):394-399.10.1016/S0194-5998(96)70208-5
Search in Google Scholar Back to article
21. Fuchs H.J., Borowitz D.S., Christiansen D.H., Morris E.M., Nash M.L., Ramsey B.W., Rosenstein B.J., Smith A.L., Wohl M.E. for the Pulmozyme Study Group - Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. N Engl J Med., 1994;331:637–642.
Search in Google Scholar Back to article
22. Quan J.M., Tiddens H.A., Sy J.P., McKenzie S.G., Montgomery M.D., Robinson P.J., Wohl M.E., Konstan M.W., Pulmozyme Early Intervention Trial Study Group - A two-year randomized, placebo-controlled trial of dornase alfa in young patients with cystic fibrosis with mild lung function abnormalities. J Pediatr., 2001;139(6):813–820.
Search in Google Scholar Back to article
23. Harms H.K., Matouk E., Tournier G., von der Hardt H., Weller P.H., Romano L., Heijerman H.G., FitzGerald M.X., Richard D., Strandvik B., Kolbe J., Kraemer R., Michalsen H. - Multicenter, open-label study of recombinant human DNase in cystic fibrosis patients with moderate lung disease. DNase International Study Group. Pediatr Pulmonol., 1998;26(3):155–161.
Search in Google Scholar Back to article
24. Konstan M.W., Schluchter M.D., Xue W., Davis P.B. - Clinical use of Ibuprofen is associated with slower FEV1 decline in children with cystic fibrosis. Am J Respir Crit Care Med., 2007;176(11):1084–1089.
Search in Google Scholar Back to article
25. Lindstrom D.R., Conley S.F., Splaingard M.L., Gershan W.M. - Ibuprofen therapy and nasal polyposis in cystic fibrosis patients. J Otolaryngol., 2007;36(5):309–314.
Search in Google Scholar Back to article
26. Suzuki H., Shimomura A., Ikeda K., Furukawa M., Oshima T., Takasaka T. - Inhibitory effect of macrolides on interleukin-8 secretion from cultured human nasal epithelial cells. Laryngoscope, 1997;107(12 Pt 1):1661–1666.10.1097/00005537-199712000-000169396683
Search in Google Scholar Back to article
27. Saiman L., Marshall B.C., Mayer-Hamblett N., Burns J.L., Quittner A.L., Cibene D.A., Coquillette S., Fieberg A.Y., Accurso F.J., Campbell P.W. 3rd; Macrolide Study Group. - Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: A randomized controlled trial. JAMA, 2003;290(13):1749–1756.10.1001/jama.290.13.174914519709
Search in Google Scholar Back to article
28. Lim M., Citardi M.J., Leong J.L. - Topical antimicrobials in the management of chronic rhinosinusitis: a systematic review. Am J Rhinol., 2008;22(4):381–389.
Search in Google Scholar Back to article
29. Kim Chiaw P., Eckford P.D., Bear C.E. - Insights into the mechanisms underlying CFTR channel activity, the molecular basis for cystic fibrosis and strategies for therapy. Essays Biochem., 2011;50(1):233–248. doi: 10.1042/bse0500233.10.1042/bse050023321967060
Search in Google Scholar Back to article
30. Pettit R.S. - Cystic fibrosis transmembrane conductance regulator-modifying medications: the future of cystic fibrosis treatment. Ann Pharmacother., 2012;46(7-8):1065–1075. doi: 10.1345/aph.1R076. Epub 2012 Jun 26.10.1345/aph.1R07622739718
Search in Google Scholar Back to article
31. Lewiston N., King V., Umetsu D., Starnes V., Marshall S., Kramer M., Theodore J. - Cystic fibrosis patients who have undergone heart-lung transplantation benefit from maxillary sinus antrostomy and repeated sinus lavage. Transplant Proc., 1991;23(1 Pt 2):1207–1208.
Search in Google Scholar Back to article
32. Rowe-Jones J.M., Mackay I.S. - Endoscopic sinus surgery in the treatment of cystic fibrosis with nasal polyposis. Laryngoscope, 1996;106(12 Pt 1):1540–1544.10.1097/00005537-199612000-000198948619
Search in Google Scholar Back to article

Articles in this issue

DOI: https://doi.org/10.1515/rjr-2017-0004 | Journal eISSN: 2393-3356 | Journal ISSN: 2069-6523

Journal RSS Feed

Language: English

Page range: 33 - 37

Published on: Mar 1, 2017

Published by: Romanian Rhinologic Society

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

Related subjects:

Clinical medicine, other,

Surgery,

Surgery, other,

Otorhinolaryngology,

Speech, voice and paediatric hearing disorders,

Oromaxillofacial surgery

© 2017 Claudiu Manea, Alina Diaconescu, published by Romanian Rhinologic Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Volume 7 (2017): Issue 25 (March 2017)